BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35504904)

  • 1. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
    Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
    Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells.
    Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.
    Liao L; Zhang YL; Deng L; Chen C; Ma XY; Andriani L; Yang SY; Hu SY; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2023 Feb; 83(3):471-484. PubMed ID: 36484700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.
    Fabris L; Berton S; Pellizzari I; Segatto I; D'Andrea S; Armenia J; Bomben R; Schiappacassi M; Gattei V; Philips MR; Vecchione A; Belletti B; Baldassarre G
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13916-21. PubMed ID: 26512117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
    Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
    Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
    Baldassarre G; Belletti B; Nicoloso MS; Schiappacassi M; Vecchione A; Spessotto P; Morrione A; Canzonieri V; Colombatti A
    Cancer Cell; 2005 Jan; 7(1):51-63. PubMed ID: 15652749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
    Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
    Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
    Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.
    Belletti B; Pellizzari I; Berton S; Fabris L; Wolf K; Lovat F; Schiappacassi M; D'Andrea S; Nicoloso MS; Lovisa S; Sonego M; Defilippi P; Vecchione A; Colombatti A; Friedl P; Baldassarre G
    Mol Cell Biol; 2010 May; 30(9):2229-40. PubMed ID: 20194624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer.
    Liu XY; Jiang W; Ma D; Ge LP; Yang YS; Gou ZC; Xu XE; Shao ZM; Jiang YZ
    Theranostics; 2020; 10(24):10940-10956. PubMed ID: 33042263
    [No Abstract]   [Full Text] [Related]  

  • 14. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.
    Zhang D; Tari AM; Akar U; Arun BK; LaFortune TA; Nieves-Alicea R; Hortobagyi GN; Ueno NT
    Mol Cancer Ther; 2010 Nov; 9(11):3090-9. PubMed ID: 21045138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
    Pujals M; Resar L; Villanueva J
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.
    Balasubramani M; Nakao C; Uechi GT; Cardamone J; Kamath K; Leslie KL; Balachandran R; Wilson L; Day BW; Jordan MA
    Mutat Res; 2011 Jun; 722(2):154-64. PubMed ID: 20816848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
    Zhao L; Zhang D; Shen Q; Jin M; Lin Z; Ma H; Huang S; Zhou P; Wu G; Zhang T
    Oncogene; 2019 Feb; 38(7):935-949. PubMed ID: 30202098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
    Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
    Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
    Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.